Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Elicio Therapeutics, Inc. (ELTX) had Operating Cash Flow per Share of $-3.04 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-51.90M |
|
-- |
|
-- |
|
$44.99M |
|
$-44.99M |
|
$-6.91M |
|
$-51.90M |
|
$-51.90M |
|
$-51.90M |
|
$-51.90M |
|
$-51.90M |
|
$-51.90M |
|
$-44.99M |
|
$-43.73M |
|
12.20M |
|
12.20M |
|
$-4.25 |
|
$-4.25 |
|
| Balance Sheet Financials | |
$20.69M |
|
$0.48M |
|
$7.49M |
|
$28.18M |
|
$11.52M |
|
$20.03M |
|
$27.97M |
|
$39.49M |
|
$-11.31M |
|
$-11.31M |
|
$-11.31M |
|
11.03M |
|
| Cash Flow Statement Financials | |
$-37.07M |
|
$-0.08M |
|
$42.32M |
|
$14.30M |
|
$19.49M |
|
$5.19M |
|
$1.45M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.80 |
|
-- |
|
-- |
|
2.30 |
|
-1.77 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-37.15M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
458.79% |
|
458.79% |
|
-184.18% |
|
-595.02% |
|
$-1.03 |
|
$-3.04 |
|
|
Operating Cash Flow per Share |
$-3.04 |